| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |